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Direct amidation of unprotected amino acids
using B(OCH2CF3)3†
Rachel M. Lanigan,‡a Valerija Karaluka,‡a Marco T. Sabatini,‡a Pavel Starkov,§a
Matthew Badland,b Lee Boultonc and Tom D. Sheppard*a
A commercially available borate ester, B(OCH2CF3)3, can be used to
achieve protecting-group free direct amidation of a-amino acids
with a range of amines in cyclopentyl methyl ether. The method can
be applied to the synthesis of medicinally relevant compounds, and
can be scaled up to obtain gram quantities of products.
Amino acids are valuable renewable chemical building blocks for
the synthesis of a wide range of natural products, pharmaceuticals
and agrochemicals, and can serve as a source of chirality for a
range of ligands and catalysts. However, their use in synthesis
relies heavily on protecting group chemistry,1 with either the
amine or the carboxylic acid requiring protection before key
bond-forming processes are carried out. Amidation is one of the
most common transformations used in the synthesis of many
industrially important molecules,2 and amino acid amides form
part of the core of numerous globally important pharmaceuticals
including sitagliptin, ramipril and lacosamide (Scheme 1).3 The
synthesis of amino acid amides typically proceeds via a three step
sequence involving protection of the nitrogen atom with a carba-
mate (Boc, Fmoc, Cbz) before amidation of the carboxylic acid and
subsequent deprotection. Nitrogen protection is usually essential
as self-reaction of the free amino acid can lead to the formation of
diketopiperazines, oligomers or polymers. The use of carbamate
protecting groups is highly ineﬃcient as they have a relatively
high molecular weight in comparison to the amino acid itself
(Boc 101; Fmoc 223; Cbz 135), and their introduction and
removal requires additional reagents, solvents and purification
materials. A more straightforward approach would be the direct
amidation of the free amino acid to give the amino amide in a
single step. This has rarely been achieved, however, with only
scattered reports in the literature that have not been widely
applied.4 The only reasonably eﬀective method involves reaction
of the amino acid with the highly toxic gas hexafluoroacetone,
followed by subsequent reaction with an amine.5 Although great
progress has been made in recent years on the development of
new amidation methods6 which make use of low-cost reagents7,8
or catalysts9 that are easy to separate from the amide products,
few of these methods are applicable to highly functionalized
compounds and none have been applied to the direct amidation
of free amino acids.10
We have recently reported the use of borate esters, and
B(OCH2CF3)3
11 in particular, for the direct amidation of a wide
range of acids and amines, including functionalized examples.8
An important advantage of this method is the ease with which the
amide products can be purified using a simple filtration work-up
involving commercially available resins, which scavenge unreacted
acid and amine as well as any boron-containing byproducts.
Scheme 1 Important amino acid amides and the typical synthetic route
used to prepare them.
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In this paper, we demonstrate that B(OCH2CF3)3 is a highly
eﬀective reagent for the direct amidation of unprotected amino
acids to give useful a-amino amide products in a single step.
This has the potential to significantly shorten the synthesis of
many pharmaceutically relevant compounds.
We began our investigation (Scheme 2 and Table 1) by
exploring the direct amidation of alanine 1a with benzylamine
2 (entry 1). Under our previous amidation conditions (MeCN,
reflux),8 addition of a base (diisopropylethylamine 3) was
necessary to solubilise alanine in the reaction. We observed a
promising 35% conversion to the desired amide using one
equivalent of B(OCH2CF3)3 4, with little evidence for significant
self-reaction of the amino acid. Addition of excess borate 4
increased the conversion to 71% (entry 2). Crucially, in the
absence of the borate reagent no conversion to the amino amide
was observed (entry 3). As the amidation product derived from
alanine was extremely polar and time-consuming to isolate, we
switched our attention to the direct amidation of phenylalanine
1bwith benzylamine 2. Under similar conditions, this amide was
obtained in 61% yield (entry 4). A screen of diﬀerent solvents,12 led
us to identify cyclopentyl methyl ether (CPME)13 as a promising
solvent for the amidation reaction (entry 5). A significant improve-
ment in the yield was seen by increasing the number of equivalents
of benzylamine 2 used (entry 6), and with excess benzylamine an
additional base was no longer required. The importance of using
B(OCH2CF3)3 as the coupling reagent was underlined by the fact
that B(OMe)3
8a led to only 9% conversion under otherwise
identical reaction conditions (entry 7). As observed previously
with alanine, no product was formed in the absence of the borate
reagent 4 (entry 8).
With an eﬀective procedure in hand, we then went on to
examine the scope with regard to the amino acid component
(Scheme 3). In order to facilitate purification of the products
we used n-propylamine as the amine so the products could be
purified via a simple solid-phase work-up and subsequent
evaporation of the volatile materials. The direct amidation
products 5a–5b derived from alanine and phenylalanine were
obtained in 71% and 90% isolated yield respectively. Other
amino acids containing alkyl/aryl side chains including glycine,
valine, leucine, proline and isoleucine also underwent direct
amidation in high yield (5c–5g), although in the case of isoleucine
a significant amount of epimerization was observed, which
Scheme 2 Direct amidation of alanine or phenylalanine using benzylamine.
Table 1 Direct amidation of 1a or 1b and 2 under a variety of conditions
Entry R Solvent 2 (eq.) 3 (eq.) 4 (eq.) Yielda
1 Me MeCN 1 1 1 (35)
2 Me MeCN 1 1 3 (71)
3 Me MeCN 1 1 0 (0)
4 Bn MeCN 1 1 3 61
5 Bn CPME 1 1 3 65
6 Bn CPME 3 0 3 95
7 Bn CPME 3 0 3b (9)
8 Bn CPME 3 0 0 (0)
a Yields measured by 1H NMR using naphthalene as an internal
standard; conversions are shown in parentheses. b B(OMe)3 was used
instead of 4.
Scheme 3 Direct amidation of unprotected amino acids with propyl-
amine; isolated yields (NMR yields shown in parentheses);14 a reaction
carried out in MeCN; b isolated as HCl salt; c125 1C; dborate 4 was added
dropwise over 1 h; e110 1C; f4 eq. of 4 and 6 eq. propylamine; gno
propylamine; h15% yield of 5n also observed; idetermined using imine
formation with a chiral aldehyde;15 jdetermined using Marfey’s reagent;16
kdetermined using a chiral shift reagent;17 ldetermined by HPLC of a
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could be reduced by reduction of the reaction time and by
adding the borate reagent dropwise.
Pleasingly, tryptophan (5h) and methionine (5i) were also
good substrates for the direct amidation reaction, giving high
yields of the corresponding amides. Even amino acids with
functionalized side chains were compatible with the reaction
conditions, with the amides derived from tyrosine (5j) and
histidine (5k) being obtained in moderate yield, and threonine
undergoing direct amidation in an impressive yield of 54%,
despite the presence of the free hydroxyl group (5l). Aspartic
acid underwent double amidation in the presence of excess
amine/borate to give the diamide 5m,18 whereas in the case of
glutamic acid, lactam formation took place alongside amida-
tion to give 5n. A small improvement in both the yield and
enantiopurity was seen by adding the borate dropwise to the
reaction mixture. Asparagine and glutamine were poor sub-
strates for the reaction giving only low conversions to the
desired amides 5o–5p. Whilst reaction of cysteine led to a good
conversion to the desired amide 5q, we were unable to purify
this amide despite numerous attempts. Lactamisation of lysine
outcompeted the desired amidation reaction with 5r being the
only product observed either in the presence or absence of
propylamine. Direct amidation of serine and arginine did not
give any of the expected amino amide. The reaction of serine
led to a complex mixture of products with no observable amide
5s, a surprising result given the successful amidation of threo-
nine. Arginine was insoluble in the reaction mixture and no 5t
was observed. Non-proteinogenic amino acids also underwent
direct amidation under these conditions (5u–5z) with b-alanine,
sarcosine and a-aminoisobutyric acid giving the corresponding
amides 5u–5w in good yield. Relatively hindered cyclopentyl
amino acid amide 5x was obtained in moderate yield, whereas
2-aminobutyric acid and O-methylserine gave the corresponding
amides 5y–5z in excellent yield. Pleasingly, the vast majority of the
amides 5a–5zwere obtained in high purity from a simple filtration
without the need for chromatography or an aqueous work-up.
Furthermore, scale-up of two amidation reactions (5b, 5e) to 1 g
scale resulted in improved yield of products whilst maintaining
the same level of enantiopurity, demonstrating the synthetic
utility of this procedure. Whilst a small degree of racemisation
was observed with some amino acids, it should be noted that the
amino amides (or simple derivatives such as their HCl salts) are
usually crystalline so recrystallization could potentially be used to
obtain enantiopure material if needed.
The scope of the reaction with regard to the amine compo-
nent was investigated next (Scheme 4), through the preparation
of amides derived from a selection of diﬀerent amines. Simple
aliphatic amines (6a–6f) including an unsaturated example (6c)
worked well in the reaction. Amides could also be prepared
from cyclic secondary amines in good yield (6g–6j). Impor-
tantly, it was also possible to prepare two dipeptide derivatives
using amino acid tert-butyl esters as the nucleophile (6k–6l).
The methodology was then applied to the synthesis of the
previously reported anti-convulsant amino amides 6m–6n19 to
demonstrate the application of the methodology. Finally, a
synthesis of the anti-epileptic lacosamide 7 was carried out by
direct amidation of (R)-1z with benzylamine, followed by acyla-
tion with acetic anhydride.20
A plausible mechanism for the amidation reactions is
shown in Scheme 5. Coordination of both the amine and the
carboxylic acid to the borate reagent should lead to cyclic
intermediate 8.4a,b This can then undergo reaction with the
amine partner to form the boron-bound amino amide 9. In
cases where the amino acid and/or the amine are less reactive,
racemisation could occur via borate-assisted deprotonation of
intermediate 8 by the amine, leading to the formation of the
formally aromatic heterocyclic enolate 10.
In summary, we have developed a practical and general
method for the protecting-group free direct amidation of free
amino acids. The amidation reaction is successful with 14 of
Scheme 4 Direct amidation reactions of amino acids with various amines;
a125 1C; bborate 4 was added dropwise over 1 h.
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the 20 common proteinogenic amino acids as well as six unnatural
amino acids, and a variety of amines can be employed. In the
majority of cases, the amino acid amide products can be isolated
using a simple filtration work-up without the need for chromato-
graphic purification. The utility of the method has been demon-
strated by the synthesis of some medicinally relevant compounds.
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